According to a recent LinkedIn post from Certify, the company is focusing on solving access and scheduling challenges in OB-GYN practices rather than underlying demand. The post describes fragmented, manual workflows that create long wait times, limited provider visibility, and patient drop-off before visits occur.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The LinkedIn post highlights that these bottlenecks can impact continuity of care and patient experience, especially in women’s health. Certify positions its offerings as a way to simplify how patients are scheduled and routed into care, suggesting a value proposition centered on operational efficiency and access optimization.
As shared in the post, Certify plans to emphasize this theme at the ACOG Annual Clinical & Scientific Meeting 2026 in Washington, D.C., where it will be present at Booth #843. For investors, this focus on OB-GYN access issues may indicate a targeted growth strategy within a niche of ambulatory care where demand is strong but workflow-related friction remains high.
If Certify can demonstrate measurable reductions in scheduling delays and patient drop-off, it could strengthen its competitive position with OB-GYN groups and larger health systems. This may support recurring revenue opportunities through software or workflow solutions tied to improved patient throughput, potentially enhancing the company’s long-term monetization prospects in women’s health operations technology.

